-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Data on recovery trajectories and long-term functional outcomes after intracerebral hemorrhage are limited
stroke
Recently , a research article was published in Stroke, an authoritative journal in the field of cardiovascular disease.
Blood vessel
Investigators performed a post hoc analysis of the i-DEF trial, a multicenter, randomized, placebo-controlled, double-blind, futility-designed Phase 2 trial based on actual treatment received
A total of 291 subjects were included in the analysis (145 placebo and 146 deferoxamine-treated)
Thus, most patients continued to improve for up to 6 months after intracerebral hemorrhage
Most patients continued to improve for up to 6 months after intracerebral hemorrhage
Original source:
Lydia Foster.